Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Debt Ratio: 2013-2025

Historic Debt Ratio for Ironwood Pharmaceuticals (IRWD) over the last 10 years, with Sep 2025 value amounting to 1.48.

  • Ironwood Pharmaceuticals' Debt Ratio rose 43.71% to 1.48 in Q3 2025 from the same period last year, while for Sep 2025 it was 4.90, marking a year-over-year increase of 5.97%. This contributed to the annual value of 1.10 for FY2024, which is 3.46% up from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Debt Ratio of 1.48 as of Q3 2025, which was down 13.39% from 1.70 recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Debt Ratio's 5-year high stood at 1.70 during Q2 2025, with a 5-year trough of 0.10 in Q4 2021.
  • Moreover, its 3-year median value for Debt Ratio was 1.08 (2024), whereas its average is 1.17.
  • Data for Ironwood Pharmaceuticals' Debt Ratio shows a peak YoY spiked of 58.61% (in 2025) over the last 5 years.
  • Over the past 5 years, Ironwood Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.10 in 2021, then reached 0.11 in 2022, then reached 1.06 in 2023, then increased by 3.46% to 1.10 in 2024, then soared by 43.71% to 1.48 in 2025.
  • Its Debt Ratio was 1.48 in Q3 2025, compared to 1.70 in Q2 2025 and 1.18 in Q1 2025.